Navigation Links
Vicus Therapeutics Announces Initiation of Phase 2 Trial to Evaluate VT-122 in Patients with Liver Cancer Receiving Nexavar
Date:12/27/2010

rtant processes that enable cancer growth.  These kinases included Raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET.  

Nexavar is currently approved in 99 countries.  

Nexavar is also being evaluated by the companies, international study groups, government agencies and individual investigators.

Important Safety Considerations For Patients Taking Nexavar

NEXAVAR in combination with carboplatin and paclitaxel is contraindicated in patients with squamous cell lung cancer. Nexavar may cause fetal harm when administered to a pregnant woman. Women of childbearing potential are advised to avoid becoming pregnant and Female patients should also be advised against breast-feeding while receiving Nexavar.

Cardiac ischemia and/or myocardial infarction may occur. Temporary or permanent discontinuation of Nexavar should be considered in patients who develop cardiac ischemia and/or myocardial infarction.  Gastrointestinal perforation was an uncommon adverse reaction and has been reported in less than 1% of patients taking Nexavar.

Uncommon but serious adverse reactions including keratoacanthomas/squamous cell cancer of the skin and Stevens - Johnson Syndrome have been reported in clinical trials

An increased risk of bleeding may occur following Nexavar administration. If bleeding necessitates medical intervention, consider discontinuation of Nexavar.

Hypertension may occur early in the course of treatment. Monitor blood pressure weekly during the first 6 weeks and periodically thereafter and treat, as required.

Hand-foot skin reaction and rash are common and management may include topical therapies for symptomatic relief.  In cases of any severe or persistent adverse reactions, temporary treatment interruption, dose modification, or permanent discontinuation of Nexavar should be considered.

Temporary interruption of Nexavar therapy is recommended in
'/>"/>

SOURCE Vicus Therapeutics, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics Records Last Patient Visit of Phase 2, VT-122 Trial for the Treatment of Cachexia in Patients With Advanced Lung Cancer
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY®
4. PTC Therapeutics Completes Enrollment of Phase 3 Trial of Ataluren in Patients with Cystic Fibrosis
5. Silence Therapeutics Provides Year-end Update
6. Angelica Therapeutics Receives a $244,479 Qualified Therapeutic Discovery Project Grant for Its Anti-Cancer Drug
7. Talecris Biotherapeutics Enrolls Patients in Clinical Trial Evaluating Two Doses of PROLASTIN®-C
8. Osseon® Therapeutics Names Gary Coughlen, CPA as New Chief Financial Officer
9. Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinsons Disease
10. Orexigen® Therapeutics Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
11. Nile Therapeutics Receives NASDAQ Notice; Will Request Hearing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 30, 2015 Future Market Insights ... "Continuous Glucose Monitoring Systems Market: Global Industry Analysis and ... the global continuous glucose monitoring systems market was valued ... to reach US$ 788.4 Mn by 2020, registering a ... 2020. Global continuous glucose monitoring systems market ...
(Date:7/30/2015)... , July 30, 2015 Vermillion, ... on gynecologic disease, announced today it will ... after the market close on Thursday, August ... call and webcast at 4:30pm Eastern.Conference Call ... at 4:30pm Eastern/1:30pm Pacific  Domestic: ...
(Date:7/30/2015)... HILLS, Calif. , July 30, 2015 /PRNewswire/ ... nanoparticle drug delivery platforms, has received Orphan Drug ... for a second drug product that uses NanoSmart,s ... a formulation of dactinomycin for the treatment of ... cancer. The FDA granted NanoSmart,s Orphan Drug Designation ...
Breaking Medicine Technology:Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4NanoSmart Receives Second FDA Orphan Drug Designation for Treatment of Pediatric Cancer 2
... provider of the award-winning PatientPad® self-service ... it has earned top honors in the "Emerging Technology ... presented by the Technology Association of Georgia (TAG) and ... this prestigious award for the PatientPad – an innovative ...
... Akron General Medical Center has joined managed technology ... communications capability and efficiency paired with major cost savings. ... with cost reductions both in short and long-term operating ... General,s strategic objectives in the coming years. ...
Cached Medicine Technology:Digital Assent Wins Back-to-Back Spirit of Endeavor Awards, This Year for Top "Emerging Technology Company" 2Digital Assent Wins Back-to-Back Spirit of Endeavor Awards, This Year for Top "Emerging Technology Company" 3Hosted Technology Exchange Welcomes Akron General 2
(Date:7/30/2015)... ... ... Ross A. Clevens, MD, FACS has been reappointed by the ... This is Dr. Clevens’ second appointment by the prestigious school. Over the ... presence and a valuable mentoring program for medical students. , The ...
(Date:7/30/2015)... ... July 30, 2015 , ... The Mesothelioma Applied ... Mesothelioma Patient Registry Act of 2015’. The bill was introduced in Congress yesterday ... (R-NY), Betty McCollum (D-MN), Joe Kennedy (D-MA), and Leonard Lance (R-NJ). The purpose ...
(Date:7/30/2015)... , ... July 30, 2015 , ... Using the latest ... and teach people more effective ways to prevent and manage major depression. , “Suicide ... fast enough, so people fall through the cracks and die needlessly everyday,” says Walker. ...
(Date:7/30/2015)... ... 2015 , ... Boston Web Marketing is proud ... Partners is the platform for search marketing agencies to communicate with the Google ... to run successful search marketing campaigns. Google Partners also affords businesses the opportunity ...
(Date:7/30/2015)... , ... July 30, 2015 , ... Between 2012 and ... the Health News Florida on June 17th. Those untreated heroin use disorders ... to prevent the spread of dirty needles throughout the community. Ultimately Florida’s HIV infection ...
Breaking Medicine News(10 mins):Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 3Health News:Bill to Create Patient Registry for Deadly Cancer Introduced in Congress 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 3Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 2Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 3
... (HealthDay News) -- Pregnant women should get a flu shot ... experts say. Pregnancy increases the risk of serious complications ... the March of Dimes. Not only does getting vaccinated ... also confer protection to the baby once it,s born, said ...
... the first time a particlular gene,s link to optimism, self-esteem and ... three critical psychological resources for coping well with stress and ... for a few years, and it is not the gene I ... UCLA and senior author of the new research. "I knew there ...
... , WEDNESDAY, Sept. 14 (HealthDay News) -- Residents of lower ... a new study finds. Sudden cardiac arrest is different ... stops beating and circulation of blood and oxygen to the ... moments. In the study, researchers from the United States ...
... The world,s health professions have launched an easy-to-use, practical ... professionals reduce the risk of noncommunicable diseases (NCDs) ... (1). The WHPA Health Improvement Card consists of a ... and health professionals. , This is part of efforts ...
... HealthDay Reporter , TUESDAY, Sept. 13 (HealthDay News) -- Preventing ... years is the goal of U.S. health officials, who launched ... aim is to raise awareness of the risk factors for ... the country; to improve access to good care; and to ...
... HealthDay Reporter , TUESDAY, Sept. 13 (HealthDay News) ... bicuspid aortic valve live in fear of sudden death, but ... life-threatening complication called aortic dissection. However, these people are ... aneurysm, or bulge in the wall of the aorta, researchers ...
Cached Medicine News:Health News:Pregnant Women Reminded to Get Flu Vaccine 2Health News:UCLA psychologists discover a gene's link to optimism, self-esteem 2Health News:UCLA psychologists discover a gene's link to optimism, self-esteem 3Health News:UCLA psychologists discover a gene's link to optimism, self-esteem 4Health News:Sudden Cardiac Arrest More Common in Poorer Neighborhoods 2Health News:Health professions launch Health Improvement Card to reduce NCD risk 2Health News:U.S. Seeks to Prevent 1 Million Heart Attacks, Strokes 2Health News:U.S. Seeks to Prevent 1 Million Heart Attacks, Strokes 3Health News:Heart Defect Seems to Pose Low Risk of Aorta Tear 2
Used with Temporary Myocardial Heartwires....
Implantable medical grade silicone end cap for insulation and sealing protection of 5 mm or 3.2 mm connectors....
... InSync ICD cardiac resynchronization and ICD device ... (BOL). The unit's RV only sensing provides ... and LV depolarizations, eliminating this cause of ... to LV separation for optimized hemodynamics. Proven ...
... The Guidant Contak Renewal 3 ... ventricular tachyarrhythmia therapy and cardiac ... right ventricular (RV) and left ... Designed to reduce irregular ventricular ...
Medicine Products: